x
Corporate Summary

Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.

 

Presentations

 

Press Releases

 

MORE



Stock Information
GANX



Contact IR

Company

GAIN THERAPEUTICS INC.

4800 Montgomery Lane Ste
220 Bethesda, MD 20814,

Phone: +1 301 500 1556

 
 

Alerts Sign Up

Form by ChronoForms - ChronoEngine.com